Literature DB >> 28101724

Drug-Drug Multicomponent Solid Forms: Cocrystal, Coamorphous and Eutectic of Three Poorly Soluble Antihypertensive Drugs Using Mechanochemical Approach.

Jamshed Haneef1, Renu Chadha2.   

Abstract

The present study deals with the application of mechanochemical approach for the preparation of drug-drug multicomponent solid forms of three poorly soluble antihypertensive drugs (telmisartan, irbesartan and hydrochlorothiazide) using atenolol as a coformer. The resultant solid forms comprise of cocrystal (telmisartan-atenolol), coamorphous (irbesartan-atenolol) and eutectic (hydrochlorothiazide-atenolol). The study emphasizes that solid-state transformation of drug molecules into new forms is a result of the change in structural patterns, diminishing of dimers and creating new facile hydrogen bonding network based on structural resemblance. The propensity for heteromeric or homomeric interaction between two different drugs resulted into diverse solid forms (cocrystal/coamorphous/eutectics) and become one of the interesting aspects of this research work. Evaluation of these solid forms revealed an increase in solubility and dissolution leading to better antihypertensive activity in deoxycorticosterone acetate (DOCA) salt-induced animal model. Thus, development of these drug-drug multicomponent solid forms is a promising and viable approach to addressing the issue of poor solubility and could be of considerable interest in dual drug therapy for the treatment of hypertension.

Entities:  

Keywords:  coamorphous; cocrystal; eutectic; mechanochemistry; multicomponent solid form

Mesh:

Substances:

Year:  2017        PMID: 28101724     DOI: 10.1208/s12249-016-0701-1

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  10 in total

Review 1.  Emerging Multi-Drug Eutectics: Opportunities and Challenges.

Authors:  Jamshed Haneef; Shakir Ali; Renu Chadha
Journal:  AAPS PharmSciTech       Date:  2021-02-07       Impact factor: 3.246

Review 2.  Engineering Cocrystals of PoorlyWater-Soluble Drugs to Enhance Dissolution in Aqueous Medium.

Authors:  Indumathi Sathisaran; Sameer Vishvanath Dalvi
Journal:  Pharmaceutics       Date:  2018-07-31       Impact factor: 6.321

Review 3.  Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review.

Authors:  Qin Shi; Fang Li; Stacy Yeh; Sakib M Moinuddin; Junbo Xin; Jia Xu; Hao Chen; Bai Ling
Journal:  AAPS PharmSciTech       Date:  2021-12-10       Impact factor: 3.246

Review 4.  Co-amorphous Drug Delivery Systems: a Review of Physical Stability, In Vitro and In Vivo Performance.

Authors:  Qin Shi; Yanan Wang; Sakib M Moinuddin; Xiaodong Feng; Fakhrul Ahsan
Journal:  AAPS PharmSciTech       Date:  2022-09-19       Impact factor: 4.026

5.  Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption.

Authors:  Noha D Fayed; Mona F Arafa; Ebtesam A Essa; Gamal M El Maghraby
Journal:  J Drug Deliv Sci Technol       Date:  2022-07-11       Impact factor: 5.062

6.  The Anti-Breast Cancer Effect and Mechanism of Glimepiride-Metformin Adduct.

Authors:  Liangyuan Long; Xiangnan Hu; Xiaoli Li; Duanfang Zhou; Yun Shi; Lingen Wang; Hongfang Zeng; Xiaoping Yu; Weiying Zhou
Journal:  Onco Targets Ther       Date:  2020-05-04       Impact factor: 4.147

7.  Physicochemical Characterization of a Co-Amorphous Atorvastatin-Irbesartan System with a Potential Application in Fixed-Dose Combination Therapy.

Authors:  Marcin Skotnicki; Barbara Jadach; Agnieszka Skotnicka; Bartłomiej Milanowski; Lidia Tajber; Marek Pyda; Jacek Kujawski
Journal:  Pharmaceutics       Date:  2021-01-18       Impact factor: 6.321

Review 8.  Drug-drug cocrystals: Opportunities and challenges.

Authors:  Xiaojuan Wang; Shuzhang Du; Rui Zhang; Xuedong Jia; Ting Yang; Xiaojian Zhang
Journal:  Asian J Pharm Sci       Date:  2020-07-09       Impact factor: 6.598

Review 9.  Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies.

Authors:  Jingwen Liu; Holger Grohganz; Korbinian Löbmann; Thomas Rades; Nele-Johanna Hempel
Journal:  Pharmaceutics       Date:  2021-03-15       Impact factor: 6.321

10.  Cyclodextrin Complexed Lipid Nanoparticles of Irbesartan for Oral Applications: Design, Development, and In Vitro Characterization.

Authors:  Narendar Dudhipala; Swetha Ettireddy; Ahmed Adel Ali Youssef; Goverdhan Puchchakayala
Journal:  Molecules       Date:  2021-12-13       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.